Evidence map›Paper›PMID 38950558›Full record

ArticleThe Lancet. Infectious diseases2024

Modelling molecular and culture-based surveillance of tetracycline resistance in Neisseria gonorrhoeae.

Kirstin I Oliveira Roster, Rachel Mittelstaedt, Jordan Reyes, Aishani V Aatresh, Yonatan H Grad

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Tetracycline-resistantJAC-antimicrobial resistance · 2025
    Review
  3. An updated molecular diagnostic for surveillance ofmedRxiv : the preprint server for health sciences · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kirstin I Oliveira RosterDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.
Rachel MittelstaedtDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Jordan ReyesDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.
Aishani V AatreshCenter for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Harvard College, Cambridge, MA, USA.
Yonatan H GradDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA 02115, USA; Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA. Electronic address: ygrad@hsph.harvard.edu.

Funding

PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeaeR01AI132606 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Yonatan H Grad · 2017 to 2026
$3.8M
NIAID NIH HHS R01 AI132606NIAID NIH HHS T32 AI007433
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsGonorrheaNeisseria gonorrhoeaeTetracycline ResistanceHumansMicrobial Sensitivity TestsTetracyclineAnti-Bacterial AgentsTetracycline

Identifiers

PMID38950558
PMCPMC11283341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.